Skip to main content
FDA Updates
Keytruda Now FDA Approved for Adjuvant Treatment of Renal-Cell Carcinoma
Read More
FDA Updates
Tecentriq First Immunotherapy FDA Approved for Adjuvant Treatment of Early-Stage Non–Small-Cell Lung Cancer
Read More
FDA Updates
Keytruda plus Chemotherapy FDA Approved for First-Line Treatment of Cervical Cancer
Read More
FDA Updates
Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer
Read More
FDA Updates
Tecartus FDA Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Read More
Meeting Highlights Online First
AVBCC 2021 Highlights
The Impact of Telehealth on Cancer Care
Read More
Meeting Highlights Online First
AVBCC 2021 Highlights
The Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs
Read More
Online First Meeting Highlights
AVBCC 2021 Highlights
Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care
Read More
Online First Meeting Highlights
AVBCC 2021 Highlights
Drug Price Reform with Value in Mind: Can It Happen?
Read More
Editorial, Chemotherapy, Obesity
Dosing Chemotherapy in Obese Patients, Still Not Answered
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
By Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Read More
Page 75 of 196
Results 741 - 750 of 1953